ICER raises cost-effective price for Pfizer's ATTR drug in final analysis but still calls for hefty discount
21st October 2024 Uncategorised 0 ICER raises cost-effective price for Pfizer’s ATTR drug in final analysis but still calls for hefty discount
aliu
Mon, 10/21/2024 – 15:00
More: ICER raises cost-effective price for Pfizer's ATTR drug in final analysis but still calls for hefty discount
Source: fierce